0001179110-14-008321.txt : 20140513 0001179110-14-008321.hdr.sgml : 20140513 20140513172253 ACCESSION NUMBER: 0001179110-14-008321 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140513 FILED AS OF DATE: 20140513 DATE AS OF CHANGE: 20140513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MERCER ROAD CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: 508-975-4820 MAIL ADDRESS: STREET 1: 2 MERCER ROAD CITY: NATICK STATE: MA ZIP: 01760 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Primiano Christopher Brett CENTRAL INDEX KEY: 0001603510 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 14838462 MAIL ADDRESS: STREET 1: 217 WEST CANTON STREET, APARTMENT 3 CITY: BOSTON STATE: MA ZIP: 02116 4 1 edgar.xml FORM 4 - X0306 4 2014-05-13 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001603510 Primiano Christopher Brett C/O KARYOPHARM THERAPEUTICS INC., 2 MERCER ROAD NATICK MA 01760 0 1 0 0 VP, GEN COUNSEL & SECRETARY Common Stock 2014-05-13 4 P 0 1000 26.75 A 1000 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.4999 to $27.00, inclusive. The reporting person undertakes to provide to Karyopharm Therapeutics Inc., any security holder of Karyopharm Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. /s/ Christopher B. Primiano 2014-05-13